Curis (CRIS) Net Interest Margin (Bank Only) %


CRIS Curis Inc CRIS
56 GF Score
Price $5.30
GF Value $1.47
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Curis Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

CRIS
56GF Score
Curis Inc CRIS
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Curis (CRIS) Overvalued in 2026?

Based on GuruFocus' analysis, Curis stock appears to be overvalued. The current stock price of $5.30 is trading 260.5% above its estimated GF Value™ of $1.47. GuruFocus considers Curis to be Significantly Overvalued.

Key valuation signals for CRIS:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: $1.47 vs. price of $5.30 (260.5% above fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the CRIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Curis Business Description

Other Exchanges CUS0:Germany
Address 128 Spring Street, Building C - Suite 500, Lexington, MA, USA, 02421
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
56GF Score

Get the complete analysis for CRIS

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.30
Price
$1.47
GF Value